Skip to Main Content

Paper Details

Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
Cancer Chemother Pharmacol
14
2019
DOX, ES, ES PDOX models, ES tumor, Ewing's sarcoma, PDOX, PDOX model, REG, Regorafenib, doxorubicin, mice, nude mice, nude mouse, patient, patients, regorafenib, tumor, tumors
Author NameAffiliation
Scott D NelsonUniversity of California los angeles
Michael BouvetUniversity of California
Robert M Hoffman
Robert M HoffmanUniversity of California
  • 1 - 4

Datasets

Release 1.2